• About
  • Masthead
  • License Content
  • Advertise
  • Submit Press Release
  • RSS/Email List
  • Write for us
  • Contact us
2 Minute Medicine
No Result
View All Result

No products in the cart.

SUBSCRIBE
  • Specialties
    • Cardiology
    • Chronic Disease
    • Dermatology
    • Emergency
    • Endocrinology
    • Gastroenterology
    • Imaging and Intervention
    • Infectious Disease
    • Nephrology
    • Neurology
    • Obstetrics
    • Oncology
    • Ophthalmology
    • Pediatrics
    • Preclinical
    • Psychiatry
    • Public Health
    • Pulmonology
    • Rheumatology
    • Surgery
  • The Scan
  • Wellness
  • Classics™
    • 2MM+ Online Access
    • Paperback and Ebook
  • Rewinds
  • Visual
  • Partners
    • License Content
    • Submit Press Release
    • Advertise with Us
  • AccountLog-in/out
    • Subscribe
    • Sign-in
    • My account
2 Minute Medicine
  • Specialties
    • Cardiology
    • Chronic Disease
    • Dermatology
    • Emergency
    • Endocrinology
    • Gastroenterology
    • Imaging and Intervention
    • Infectious Disease
    • Nephrology
    • Neurology
    • Obstetrics
    • Oncology
    • Ophthalmology
    • Pediatrics
    • Preclinical
    • Psychiatry
    • Public Health
    • Pulmonology
    • Rheumatology
    • Surgery
  • The Scan
  • Wellness
  • Classics™
    • 2MM+ Online Access
    • Paperback and Ebook
  • Rewinds
  • Visual
  • Partners
    • License Content
    • Submit Press Release
    • Advertise with Us
  • AccountLog-in/out
    • Subscribe
    • Sign-in
    • My account
SUBSCRIBE
2 Minute Medicine
Subscribe
Home All Specialties Chronic Disease

Video-based behavioral intervention benefits clinical skin examinations

byAdam WhittingtonandAngela Wang
February 25, 2014
in Chronic Disease, Dermatology, Oncology
Reading Time: 2 mins read
0
Share on FacebookShare on Twitter

Image: PD 

1. In men 50 years or older, video-based skin awareness material correlated with higher rates of whole-body clinical skin examinations and skin cancer diagnosis. 

Evidence Rating: 1 (Excellent) 

Study Rundown: Early-detection and removal of melanoma lowers morbidity and mortality rates. Some studies have shown that skin examination screening may offer a survival benefit in such cases. However, older men are less likely to participate in routine clinical skin examinations (CSEs), despite increasing mortality rates compared to other groups. As such, this study investigates the effectiveness of video-based skin cancer education on CSE behaviors. These authors found that intervention increased rates of whole-body CSE within 6 months compared to the control group. Additionally, the intervention group was diagnosed with a higher proportion of malignant lesions. Strengths of this study include confirmation of self-reported CSE rate by physicians and the study’s focus on men aged >50 years, a high-risk group. However, limitations do exist. Men who enrolled in this study may have been more health-conscious than represented in the general population, leading to a potential overestimation of benefit to the general population. Future studies may focus on whether CSE screening confers a mortality benefit.

Click to read the study in JAMA Dermatology

Relevant Reading: Skin self-examination education for early detection of melanoma: a randomized controlled trial of Internet, workbook, and in-person interventions

In-Depth [randomized controlled trial]: This study enrolled 930 men aged at least 50 years from the Queensland area. Video and written educational material on melanoma skin cancer was given to the intervention group while the control group received only written materials. Results indicated that participants who received both video and written education were more likely than those who received only written materials to report whole-body CSE during the first 6 months of intervention (35.3% vs. 27.2%; P = .01). Additionally, the Cohen Îş test was used to analyze agreement between participant-reported and physician-reported data, which confirmed that the intervention group was more likely to have undergone a whole-body CSE than those in the control group (74.5% vs. 61.4%; P = .046). Notably, skin lesions that required some form of management were detected in 76.3% of men with a physician-reported CSE. Significantly more of those cancers were identified in the intervention group than the control group (60.0% vs. 40.0%; P = .03), suggesting video-based behavioral intervention led to early detection of skin cancers and increased whole-body CSE in older men.

RELATED REPORTS

#VisualAbstract: Nivolumab plus ipilimumab improves recurrence-free survival in patients with resected advanced melanoma

The Scan by 2 Minute Medicine®: World Mental Health Day, Beneath the Band-aid, Trouble in Uganda and Carbon Monoxide Leak Sickens Dozens!

Nivolumab plus ipilimumab improves recurrence-free survival in patients with resected advanced melanoma

©2012-2014 2minutemedicine.com. All rights reserved. No works may be reproduced without expressed written consent from 2minutemedicine.com. Disclaimer: We present factual information directly from peer reviewed medical journals. No post should be construed as medical advice and is not intended as such by the authors, editors, staff or by 2minutemedicine.com. PLEASE SEE A HEALTHCARE PROVIDER IN YOUR AREA IF YOU SEEK MEDICAL ADVICE OF ANY SORT. 

Tags: skin cancer
Previous Post

Smoking may not affect short-term outcomes in cranial surgery

Next Post

Addition of bevacizumab fails to benefit overall survival in newly diagnosed glioblastoma [RTOG 0825 trial]

RelatedReports

#VisualAbstract: Pembrolizumab provides survival benefit in PD-L1 positive advanced head and neck cancer
StudyGraphics

#VisualAbstract: Nivolumab plus ipilimumab improves recurrence-free survival in patients with resected advanced melanoma

October 20, 2022
The Scan by 2 Minute Medicine®:  Ultra-Trail du Mont-Blanc, Taylor Swift, NBA rookie Chet Holmgren and Magic Mushrooms!
The Scan by 2 Minute Medicine®

The Scan by 2 Minute Medicine®: World Mental Health Day, Beneath the Band-aid, Trouble in Uganda and Carbon Monoxide Leak Sickens Dozens!

October 18, 2022
Adding sargramostim to ipilimumab may improve survival in advanced melanoma
Chronic Disease

Nivolumab plus ipilimumab improves recurrence-free survival in patients with resected advanced melanoma

October 12, 2022
PD-1 blocker pembrolizumab may be a promising therapy for advanced Merkel-cell carcinoma
Chronic Disease

Stereotactic body radiation does not improve outcomes in patients with advanced Merkel cell carcinoma receiving nivolumab and ipilimumab

October 7, 2022
Next Post
Addition of bevacizumab fails to benefit overall survival in newly diagnosed glioblastoma [RTOG 0825 trial]

Addition of bevacizumab fails to benefit overall survival in newly diagnosed glioblastoma [RTOG 0825 trial]

Pre-operative transcranial magnetic stimulation useful for language mapping

First line bevacizumab fails to improve survival newly diagnosed glioblastoma patients [AVAglio trial]

Classics Series, Landmark Trials in Medicine

CT scans associated with increased risk of malignancy [Pediatrics Classics Series]

License Our Award-Winning Physician-Written Medical News and Visual Abstracts

2 Minute Medicine is the leading authoritative medical news licensing service, and the only with reports written by practicing doctors.

LICENSE CONTENT

2MM+ Premium Access

No ads & unlimited access to all current reports, over 9000 searchable archived reports, visual abstracts, Weekly Rewinds, and the online edition of The Classics Series™ textbook.

Subscription Options
2 Minute Medicine

2 Minute Medicine® is an award winning, physician-run, expert medical media company. Our content is curated, written and edited by practicing health professionals who have clinical and scientific expertise in their field of reporting. Our editorial management team is comprised of highly-trained MD physicians. Join numerous brands, companies, and hospitals who trust our licensed content.

Recent Reports

  • BNT162b2 booster is safe and reduces COVID-19 transmission in older adults
  • Bisphosphonates, denosumab, abaloparatide, teriparatide, and romosozumab reduce postmenopausal fracture risk
  • Epstein-Barr viral load monitoring reduces risk of post-liver transplant lymphoproliferative disease
License Content
Terms of Use | Disclaimer
Cookie Policy
Privacy Statement (EU)
Disclaimer

© 2021 2 Minute Medicine, Inc. - Physician-written medical news.

  • Specialties
    • Cardiology
    • Chronic Disease
    • Dermatology
    • Emergency
    • Endocrinology
    • Gastroenterology
    • Imaging and Intervention
    • Infectious Disease
    • Nephrology
    • Neurology
    • Obstetrics
    • Oncology
    • Ophthalmology
    • Pediatrics
    • Preclinical
    • Psychiatry
    • Public Health
    • Pulmonology
    • Rheumatology
    • Surgery
  • The Scan
  • Wellness
  • Classics™
    • 2MM+ Online Access
    • Paperback and Ebook
  • Rewinds
  • Visual
  • Partners
    • License Content
    • Submit Press Release
    • Advertise with Us
  • Account
    • Subscribe
    • Sign-in
    • My account

© 2021 2 Minute Medicine, Inc. - Physician-written medical news.

Want more physician-written
medical news?

Join over 10 million yearly readers and numerous companies. For healthcare professionals
and the public.

Subscribe for free today!

Subscription options